Index by author
Bargout, Raed
Eras, Tomris
- Recognizing and treating diabetic autonomic neuropathy
Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.
Jaber, Wael A.
How often are atrial septal defects associated with thromboembolism? When should they be looked for?In the absence of other causative conditions, an atrial septal defect may be presumed to be the underlying cause of a stroke, especially in younger patients.
Kalaycio, Matt E.
- Chronic myelogenous leukemia: The news you have and haven’t heard
One major advance in treating CML was widely publicized. Another, although equally important, was not.
Klein, Allan L.
- How often are atrial septal defects associated with thromboembolism? When should they be looked for?
In the absence of other causative conditions, an atrial septal defect may be presumed to be the underlying cause of a stroke, especially in younger patients.
Leonard, Mandy
- Role of alendronate and risedronate in preventing and treating osteoporosis
A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.
Licata, Angelo A.
- Role of alendronate and risedronate in preventing and treating osteoporosis
A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.
Lipani, John
- Cox - 2 Inhibitors and Cardiovascular Risk
Unless a clear cause-and-effect relationship can be proved between COX-2 inhibitors and cardiovascular events, we should go on using these drugs.
Malhotra, Amit
Mandell, Brian F.
- Cox - 2 Inhibitors and Cardiovascular Risk
Even if we do not know with certainty whether COX-2 inhibitors increase the risk of cardiovascular events, we need to incorporate this concern into our practice.
- COX-2 inhibitors: Balancing the hope, the hype, and the concern
When all is said and done, the choice rests with the individual prescribing physician.
